EdgarLookup
6-K

INNATE PHARMA S.A. 6-K

Company
Innate Pharma SA
Filed
May 3, 2022
Period of Report
May 2, 2022
Accession Number
0001157523-22-000532
View Document ↗ View on SEC.gov ↗